Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CVTX - CV Therapeutics, Inc. -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (111)	11/3/2003 4:30:35 PM
From: A.J. Mullen	Read Replies (1) \| Respond to of 411

Clearly there's a lot I don't know about the approval process. I thought an AC meeting was the norm. Is that not so? I remember the company being asked about the Qt interval at H&Q in January. The response was that they expected questions to be asked, but that the prolongation was small compared to the observed range. I wasn't convinced by that; a bias that is small compared to the observed variance can still affect the expectation substantially. On the otherhand, maybe the interval between firing and recovery has little importance? Ashley